Neurotrophin Signaling in the Human Trabecular Meshwork
Principal Investigator
Robert Wordinger, PhD
University of North Texas Health Science Center
Fort Worth, TX, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$47,026
Active Dates
April 01, 1999 - March 31, 2001
Grant ID
G1999017
Summary
The trabecular meshwork is an intricate system of drainage canals through which the intraocular fluid, also called the aqueous humor, drains from the eye. This drainage helps the eye maintain normal fluid pressure. Dr. Wordinger has hypothesized that a certain class of growth factors, called neurotrophins, play an important role in cells of the trabecular meshwork (TM). He hopes to improve our knowledge of the normal physiology of aqueous humor outflow via the TM and to determine if neurotrophins play a role in glaucoma. If the latter proves to be true, existing compounds for regulating neurotrophins can be tested for their therapeutic value.
Related Grants
National Glaucoma Research
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dan Stamer, PhD
Current Organization
Duke University School of Medicine
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dan Stamer, PhD
Current Organization
Duke University School of Medicine
National Glaucoma Research
Enhancing Access to Glaucoma Care Using Artificial Intelligence
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Benjamin Xu, MD, PhD
Current Organization
University of Southern California
Enhancing Access to Glaucoma Care Using Artificial Intelligence
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Benjamin Xu, MD, PhD
Current Organization
University of Southern California
National Glaucoma Research
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute